Short Interest in iShares Health Innovation Active ETF (NYSEARCA:BMED) Drops By 90.9%

iShares Health Innovation Active ETF (NYSEARCA:BMED) was the target of a large decline in short interest in December. As of December 15th, there was short interest totaling 4,806 shares, a decline of 90.9% from the November 30th total of 52,638 shares. Based on an average daily volume of 3,507 shares, the short-interest ratio is currently 1.4 days. Currently, 2.4% of the company’s stock are sold short. Currently, 2.4% of the company’s stock are sold short. Based on an average daily volume of 3,507 shares, the short-interest ratio is currently 1.4 days.

iShares Health Innovation Active ETF Stock Performance

NYSEARCA BMED traded up $0.16 during trading hours on Wednesday, reaching $30.84. 1,181 shares of the company’s stock were exchanged, compared to its average volume of 2,208. The company has a market capitalization of $6.17 million, a price-to-earnings ratio of 24.91 and a beta of 0.84. The company’s 50-day moving average is $29.47 and its two-hundred day moving average is $27.02. iShares Health Innovation Active ETF has a one year low of $20.57 and a one year high of $30.95.

iShares Health Innovation Active ETF Company Profile

The BlackRock Future Health ETF (BMED) is an exchange-traded fund that is based on the MSCI All Country World index. The fund is actively managed to invest in global equities in the health sciences industry. BMED was launched on Sep 29, 2020 and is managed by BlackRock.